These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1269 related articles for article (PubMed ID: 29860075)
1. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial. Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ; JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075 [TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk. Baron SJ; Wang K; House JA; Magnuson EA; Reynolds MR; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Mack MJ; Brown DL; Russo MJ; Smith CR; Webb J; Miller C; Leon MB; Cohen DJ Circulation; 2019 Feb; 139(7):877-888. PubMed ID: 30586747 [TBL] [Abstract][Full Text] [Related]
3. Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial. Baron SJ; Arnold SV; Wang K; Magnuson EA; Chinnakondepali K; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Brown DL; Mack MJ; Smith CR; Leon MB; Cohen DJ; JAMA Cardiol; 2017 Aug; 2(8):837-845. PubMed ID: 28658491 [TBL] [Abstract][Full Text] [Related]
4. Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients. Kleiman NS; Van Mieghem NM; Reardon MJ; Gada H; Mumtaz M; Olsen PS; Heiser J; Merhi W; Chetcuti S; Deeb GM; Chawla A; Kiaii B; Teefy P; Chu MWA; Yakubov SJ; Windecker S; Althouse AD; Baron SJ JACC Cardiovasc Interv; 2024 Apr; 17(8):979-988. PubMed ID: 38658126 [TBL] [Abstract][Full Text] [Related]
5. Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial. Pibarot P; Salaun E; Dahou A; Avenatti E; Guzzetti E; Annabi MS; Toubal O; Bernier M; Beaudoin J; Ong G; Ternacle J; Krapf L; Thourani VH; Makkar R; Kodali SK; Russo M; Kapadia SR; Malaisrie SC; Cohen DJ; Leipsic J; Blanke P; Williams MR; McCabe JM; Brown DL; Babaliaros V; Goldman S; Szeto WY; Généreux P; Pershad A; Alu MC; Xu K; Rogers E; Webb JG; Smith CR; Mack MJ; Leon MB; Hahn RT; Circulation; 2020 May; 141(19):1527-1537. PubMed ID: 32272848 [TBL] [Abstract][Full Text] [Related]
6. Outcomes of SAPIEN 3 Transcatheter Aortic Valve Replacement Compared With Surgical Valve Replacement in Intermediate-Risk Patients. Madhavan MV; Kodali SK; Thourani VH; Makkar R; Mack MJ; Kapadia S; Webb JG; Cohen DJ; Herrmann HC; Williams M; Greason K; Pibarot P; Hahn RT; Jaber W; Xu K; Alu M; Smith CR; Leon MB J Am Coll Cardiol; 2023 Jul; 82(2):109-123. PubMed ID: 37407110 [TBL] [Abstract][Full Text] [Related]
7. Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction. Little SH; Oh JK; Gillam L; Sengupta PP; Orsinelli DA; Cavalcante JL; Chang JD; Adams DH; Zorn GL; Pollak AW; Abdelmoneim SS; Reardon MJ; Qiao H; Popma JJ Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313280 [TBL] [Abstract][Full Text] [Related]
8. Impact of Flow on Prosthesis-Patient Mismatch Following Transcatheter and Surgical Aortic Valve Replacement. Abbas AE; Ternacle J; Pibarot P; Xu K; Alu M; Rogers E; Hahn RT; Leon M; Thourani VH Circ Cardiovasc Imaging; 2021 Aug; 14(8):e012364. PubMed ID: 34387097 [TBL] [Abstract][Full Text] [Related]
9. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial. Chen S; Redfors B; Ben-Yehuda O; Crowley A; Greason KL; Alu MC; Finn MT; Vahl TP; Nazif T; Thourani VH; Suri RM; Svensson L; Webb JG; Kodali SK; Leon MB JACC Cardiovasc Interv; 2018 Nov; 11(21):2207-2216. PubMed ID: 30409278 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience. Garcia S; Kelly R; Mbai M; Gurevich S; Oestreich B; Yannopoulos D; Adabag S Catheter Cardiovasc Interv; 2018 Aug; 92(2):390-398. PubMed ID: 29316204 [TBL] [Abstract][Full Text] [Related]
11. Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial. Pibarot P; Ternacle J; Jaber WA; Salaun E; Dahou A; Asch FM; Weissman NJ; Rodriguez L; Xu K; Annabi MS; Guzzetti E; Beaudoin J; Bernier M; Leipsic J; Blanke P; Clavel MA; Rogers E; Alu MC; Douglas PS; Makkar R; Miller DC; Kapadia SR; Mack MJ; Webb JG; Kodali SK; Smith CR; Herrmann HC; Thourani VH; Leon MB; Hahn RT; J Am Coll Cardiol; 2020 Oct; 76(16):1830-1843. PubMed ID: 33059828 [TBL] [Abstract][Full Text] [Related]
12. 5-Year Outcomes Comparing Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney Disease. Garcia S; Cubeddu RJ; Hahn RT; Ternacle J; Kapadia SR; Kodali SK; Thourani VH; Jaber WA; Asher CR; Elmariah S; Makkar R; Webb JG; Herrmann HC; Lu M; Devireddy CM; Malaisrie SC; Smith CR; Mack MJ; Sorajja P; Cavalcante JL; Goessl M; Shroff GR; Leon MB; Pibarot P JACC Cardiovasc Interv; 2021 Sep; 14(18):1995-2005. PubMed ID: 34556273 [TBL] [Abstract][Full Text] [Related]
14. Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy. Gada H; Kirtane AJ; Wang K; Lei Y; Magnuson E; Reynolds MR; Williams MR; Kodali S; Vahl TP; Arnold SV; Leon MB; Thourani V; Szeto WY; Cohen DJ; Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):338-46. PubMed ID: 26058718 [TBL] [Abstract][Full Text] [Related]
15. Bioprosthetic Valve Performance After Transcatheter Aortic Valve Replacement With Self-Expanding Versus Balloon-Expandable Valves in Large Versus Small Aortic Valve Annuli: Insights From the CHOICE Trial and the CHOICE-Extend Registry. Abdelghani M; Mankerious N; Allali A; Landt M; Kaur J; Sulimov DS; Merten C; Sachse S; Mehilli J; Neumann FJ; Frerker C; Kurz T; El-Mawardy M; Richardt G; Abdel-Wahab M JACC Cardiovasc Interv; 2018 Dec; 11(24):2507-2518. PubMed ID: 30503595 [TBL] [Abstract][Full Text] [Related]
16. Mid-Term Outcomes of Transcatheter Aortic Valve Replacement in Extremely Large Annuli With Edwards SAPIEN 3 Valve. Sengupta A; Zaid S; Kamioka N; Terre J; Miyasaka M; Hirji SA; Hensey M; Geloo N; Petrossian G; Robinson N; Sarin E; Ryan L; Yoon SH; Tan CW; Khalique OK; Kodali SK; Kaneko T; Shah PB; Wong SC; Salemi A; Sharma K; Kozina JA; Szerlip MA; Don CW; Gafoor S; Zhang M; Newhart Z; Kapadia SR; Mick SL; Krishnaswamy A; Kini A; Ahmad H; Lansman SL; Mack MJ; Webb JG; Babaliaros V; Thourani VH; Makkar RR; Leon MB; George I; Tang GHL JACC Cardiovasc Interv; 2020 Jan; 13(2):210-216. PubMed ID: 31883715 [TBL] [Abstract][Full Text] [Related]
17. Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts. Szerlip M; Gualano S; Holper E; Squiers JJ; White JM; Doshi D; Williams MR; Hahn RT; Webb JG; Svensson LG; Kirtane AJ; Cohen DJ; Douglas PS; Alu MC; Crowley A; Tuzcu EM; Makkar RR; Herrmann HC; Babaliaros V; Thourani VH; Leon MB; Kodali SK; Mack MJ JACC Cardiovasc Interv; 2018 Jan; 11(1):13-20. PubMed ID: 29301644 [TBL] [Abstract][Full Text] [Related]
18. Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: A meta-analysis of randomized trials and propensity score matched observational studies. Witberg G; Lador A; Yahav D; Kornowski R Catheter Cardiovasc Interv; 2018 Aug; 92(2):408-416. PubMed ID: 29388308 [TBL] [Abstract][Full Text] [Related]
19. Rationale and design of a prospective, randomized, controlled, multicenter study to evaluate the safety and efficacy of transcatheter heart valve replacement in female patients with severe symptomatic aortic stenosis requiring aortic valve intervention (Randomized researcH in womEn all comers wIth Aortic stenosis [RHEIA] trial). Eltchaninoff H; Bonaros N; Prendergast B; Nietlispach F; Vasa-Nicotera M; Chieffo A; Pibarot P; Bramlage P; Sykorova L; Kurucova J; Bax JJ; Windecker S; Dumonteil N; Tchetche D Am Heart J; 2020 Oct; 228():27-35. PubMed ID: 32745733 [TBL] [Abstract][Full Text] [Related]